Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/22/2005US20050208489 Targeted chromosomal mutagenasis using zinc finger nucleases
09/22/2005US20050208487 Using fixed spiegelmer to remove preferential particles from blood sample; apheresis
09/22/2005US20050208485 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes and uses thereof
09/22/2005US20050208484 Isolated nucleic acid molecules encoding human drugmetobolizing proteins
09/22/2005US20050208482 Tat-based immunomodulatory compositions and methods for their discovery and use
09/22/2005US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection
09/22/2005US20050208479 Immunoglobulin for prevention of variola infection; immunotherapeutics
09/22/2005US20050208474 Method and cell composition for screening compounds for anti-inflammatory activity
09/22/2005US20050208463 Method of screening drug
09/22/2005US20050208079 Glucan-based vaccines
09/22/2005US20050208074 Anticancer agents; gene therapy; trimers; host cells; genomes
09/22/2005US20050208071 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species
09/22/2005US20050208068 Malaria immunogen and vaccine
09/22/2005US20050208066 Fusion proteins; severe acute respiratory syndrome coronavirus; double-stranded RNA; drug screening
09/22/2005US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
09/22/2005US20050208063 Vaccine containing a thiol protease
09/22/2005US20050208062 Compositions and methods relating to hepatic specific genes and proteins
09/22/2005US20050208058 For treatment of cell proliferative by modulating/inhibiting centrosomal genes or polypeptides via gene silencing, antibodies, aptamers, ribozymes, and antisense nucleic acids; gene expression inhibition; tubulins
09/22/2005US20050208056 Neoplasm specific antibodies and uses thereof
09/22/2005US20050208053 Administering very late antigen-4, antigen binding fragment thereof, soluble vascular cell adhesion molecule-1 polypeptide; chimera
09/22/2005US20050208050 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
09/22/2005US20050208046 TWEAK receptor
09/22/2005US20050208044 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050208040 Polynucleotides and polypeptides encoded thereby
09/22/2005US20050208032 Oral administration of therapeutic agent coupled to transporting agent
09/22/2005US20050208031 Identify agonist exhibiting pharmacologic molecular biologic inhibition effective against the activity of the iPLA2 beta and iPLA2 gamma isoforms; transfect the cells with siRNA prior to induction of differentiation; observe if down regulation inhibits or controls adipocyte chemisty; obesity therapy
09/22/2005US20050208030 Myocardial grafts and cellular compositions useful for same
09/22/2005US20050208023 Inhibiting tumor angiogenesis by engineered over expression of Von Hippel-Lindau; nucleic acid vector is in a viral capsid; administered intratumorally
09/22/2005US20050208022 Gene introduced into a retinal cell, encoding photosensitive protein; horizontal cells, amacrine cells, bipolar cells, and ganglion cells; photoreceptor cell degeneration; retinitis pigmentosa, macular degeneration, age-related macular degeneration
09/22/2005US20050208021 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
09/22/2005US20050205833 Recombinant peptide
09/22/2005DE102004010928A1 Enriching prokaryotic DNA from solution, useful e.g. for early diagnosis of bacterial infection, by treatment with protein that binds selectively to non-methylated CpG motifs then separating the complex formed
09/22/2005DE102004010023A1 Bakterielles System zum Proteintransport in eukaryontische Zellen Bacterial system for protein delivery into eukaryotic cells
09/22/2005DE102004009977A1 New nucleic acid containing fluorescent tricyclic heterocyclic residue, useful as hybridization probes for detection and quantification of nucleic acids
09/22/2005CA2564614A1 Combinatorial interleukin-2 muteins
09/22/2005CA2559550A1 Thiol methyltransferase-based selection
09/22/2005CA2559390A1 Infectious aetiology of prostatic disease and methods to identify causative agents
09/22/2005CA2559172A1 Therapeutic use of rm1 antigen
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2559055A1 Modified oncolytic viruses
09/22/2005CA2558911A1 Process for producing polypeptides
09/22/2005CA2558815A1 Barley for production of flavor-stable beverage
09/22/2005CA2558811A1 Dimeric fusion proteins and materials and methods for producing them
09/22/2005CA2558771A1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
09/22/2005CA2558641A1 Artificial mutation controls for diagnostic testing
09/22/2005CA2558632A1 Improved interleukin-2 muteins
09/22/2005CA2558621A1 Promoter from maize prolamin seed storage protein and uses thereof
09/22/2005CA2558041A1 Polynucleotides for the detection of escherichia coli o157
09/22/2005CA2558025A1 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
09/22/2005CA2557668A1 High efficiency peptide production in plant cells
09/22/2005CA2557633A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
09/22/2005CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
09/22/2005CA2555541A1 Cd38 splice variant and uses thereof
09/22/2005CA2541177A1 Vectors for directional cloning
09/21/2005EP1577396A1 Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes
09/21/2005EP1577395A1 Artificial promoter for the expression of dna sequences in vegetal cells
09/21/2005EP1577394A1 DNA fragment containing biotin biosynthesis gene and utilization thereof
09/21/2005EP1577393A1 PRIMER AND PROBE FOR DETECTING i VIBRIO CHOLERAE /i OR i VIBRIO MIMICUS /i AND DETECTION METHOD USING THE SAME
09/21/2005EP1577392A1 Method for producing a transgenic plant with the aid of agrobacterium tumefaciens
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577390A1 Human cancer-relating genes, the products encoded thereby and applications thereof
09/21/2005EP1577389A2 Magnetic pigment
09/21/2005EP1577388A1 Adiponectin promoter and use thereof
09/21/2005EP1577387A1 Preventives/remedies for cancer
09/21/2005EP1577386A2 Method for producing purine nucleosides by fermentation
09/21/2005EP1577384A1 Plant with reduced protein content in seed, method of constructing the same and method of using the same
09/21/2005EP1577383A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof
09/21/2005EP1577322A1 Novel proteins and use thereof
09/21/2005EP1577011A2 Disruption of cells and tissues
09/21/2005EP1576966A1 Method of preparing a vaccine and anti-tumor vaccines
09/21/2005EP1576878A1 Glyt1 transgenic mice
09/21/2005EP1576877A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576190A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
09/21/2005EP1576186A1 Method for generating a genetically modified organism for screening active substances
09/21/2005EP1576185A1 Method for detecting mutations
09/21/2005EP1576184A2 Method for the in vitro selection of binders
09/21/2005EP1576183A4 Method for correlating gene expression profiles with protein expression profiles
09/21/2005EP1576183A2 Method for correlating gene expression profiles with protein expression profiles
09/21/2005EP1576178A2 Cell proliferation-related polypeptides and uses therefor
09/21/2005EP1576176A2 Short interfering nucleic acid hybrids and methods thereof
09/21/2005EP1576175A2 Vascular-preferred promoters
09/21/2005EP1576171A2 Amino acid transporters
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576166A2 Novel method for the production of polyunsaturated fatty acids
09/21/2005EP1576165A2 Methods for increasing total oil levels in plants
09/21/2005EP1576164A2 Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content
09/21/2005EP1576163A2 High-protein-phenotype-associated plant genes
09/21/2005EP1576162A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors
09/21/2005EP1576161A1 A salt tolerant l-myo-inositol 1 phosphate synthase and the process of obtaining the same
09/21/2005EP1576160A2 Borrelidin-producing polyketide synthase and its use
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1576158A2 Actinobacillus pleuropneumoniae virulence genes
09/21/2005EP1576157A1 Fluorescent proteins from copepoda species and methods for using same
09/21/2005EP1576156A1 Dec-205 (ly 75) / dcl-1 intergenic splice variants associated with hodkin's disease, and uses thereof
09/21/2005EP1576155A1 Oligoribonucleotides for treating degenerative skin disorders by rna interference
09/21/2005EP1576154A1 In vivo affinity maturation scheme
09/21/2005EP1576152A1 Thermostable alpha-amylases
1 ... 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 ... 4023